BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,552,049 | +5.1% | 2,479,103 | +4.5% | 1.48% | +6.4% |
Q2 2023 | $16,699,676 | -55.7% | 2,372,113 | -47.5% | 1.40% | -46.9% |
Q1 2023 | $37,702,838 | +273.0% | 4,520,724 | +413.4% | 2.63% | +197.1% |
Q4 2022 | $10,107,991 | +175.9% | 880,487 | +79.0% | 0.88% | +105.8% |
Q4 2020 | $3,664,297 | -6.7% | 491,852 | -57.0% | 0.43% | -50.7% |
Q3 2020 | $3,926,930 | -83.0% | 1,143,211 | -76.4% | 0.87% | -72.4% |
Q2 2020 | $23,099,729 | +53.1% | 4,847,792 | -35.7% | 3.17% | -15.5% |
Q1 2020 | $15,084,744 | -10.8% | 7,542,372 | +53.8% | 3.75% | +25.5% |
Q4 2019 | $16,920,387 | +802.4% | 4,904,460 | +649.4% | 2.99% | +413.4% |
Q3 2019 | $1,875,028 | +11.4% | 654,460 | +47.3% | 0.58% | +23.6% |
Q2 2019 | $1,683,745 | -49.9% | 444,260 | +7.6% | 0.47% | -51.9% |
Q1 2019 | $3,360,811 | +154.0% | 412,876 | +151.8% | 0.98% | +36.9% |
Q4 2018 | $1,323,149 | +16.4% | 163,959 | +10.1% | 0.72% | +43.5% |
Q3 2018 | $1,136,557 | +33.2% | 148,959 | 0.0% | 0.50% | +27.9% |
Q2 2018 | $853,535 | +20.1% | 148,959 | 0.0% | 0.39% | +18.2% |
Q1 2018 | $710,534 | -27.0% | 148,959 | -24.9% | 0.33% | -41.1% |
Q4 2017 | $973,746 | – | 198,319 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |